Babaoglu, H. Et Al. 2019. Tofacitinib for the Treatment of Refractory Polymyositis. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.25, no.8 .

Babaoglu, H., Varan, O., Atas, N., SATIŞ, H., Salman, R., & TUFAN, A., (2019). Tofacitinib for the Treatment of Refractory Polymyositis. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.25, no.8.

Babaoglu, Hakan Et Al. "Tofacitinib for the Treatment of Refractory Polymyositis," JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.25, no.8, 2019

Babaoglu, Hakan Et Al. "Tofacitinib for the Treatment of Refractory Polymyositis." JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.25, no.8, 2019

Babaoglu, H. Et Al. (2019) . "Tofacitinib for the Treatment of Refractory Polymyositis." JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.25, no.8.

@article{article, author={Hakan Babaoglu Et Al. }, title={Tofacitinib for the Treatment of Refractory Polymyositis}, journal={JCR-JOURNAL OF CLINICAL RHEUMATOLOGY}, year=2019}